| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.63B | -8.4% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥-0.10B | — |
| Net income | ¥-0.10B | — |
| Gross margin | 14.1% | Net margin -15.2% |
| Revenue Q/Q | -66.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.54B | 85.9% |
| R&D | ¥0.06B | 9.8% |
| SG&A | ¥0.12B | 18.5% |
| Tax & other | ¥0.00B | 0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华星创业 ・ 红日药业 ・ ST华谊 ・ 阳普医疗 ・ 宝通科技 ・ 金龙机电 ・ 钢研高纳 ・ 中科电气 ・ 超图软件 ・ 新宙邦 ・ 上海凯宝 ・ 九洲集团
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies